These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34279913)

  • 61. Androgenetic alopecia: an update.
    Kaliyadan F; Nambiar A; Vijayaraghavan S
    Indian J Dermatol Venereol Leprol; 2013; 79(5):613-25. PubMed ID: 23974579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIF-1α Stimulators Function Equally to Leading Hair Loss Agents in Enhancing Dermal Papilla Growth.
    Bukowiecki J; Pförringer D; Thor D; Duscher D; Brett E
    Skin Pharmacol Physiol; 2020; 33(6):309-316. PubMed ID: 33326985
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation.
    Ghonemy S; Alarawi A; Bessar H
    J Dermatolog Treat; 2021 Mar; 32(2):236-241. PubMed ID: 31403367
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
    Panahi Y; Taghizadeh M; Marzony ET; Sahebkar A
    Skinmed; 2015; 13(1):15-21. PubMed ID: 25842469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Promising therapies for treating and/or preventing androgenic alopecia.
    McElwee KJ; Shapiro JS
    Skin Therapy Lett; 2012 Jun; 17(6):1-4. PubMed ID: 22735503
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential Expression between Human Dermal Papilla Cells from Balding and Non-Balding Scalps Reveals New Candidate Genes for Androgenetic Alopecia.
    Chew EGY; Tan JHJ; Bahta AW; Ho BS; Liu X; Lim TC; Sia YY; Bigliardi PL; Heilmann S; Wan ACA; Nöthen MM; Philpott MP; Hillmer AM
    J Invest Dermatol; 2016 Aug; 136(8):1559-1567. PubMed ID: 27060448
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double-blind, randomized controlled trial study.
    Masoud F; Alamdari HA; Asnaashari S; Shokri J; Javadzadeh Y
    Dermatol Ther; 2020 Nov; 33(6):e14467. PubMed ID: 33112463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
    J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Androgenetic alopecia: combining medical and surgical treatments.
    Bouhanna P
    Dermatol Surg; 2003 Nov; 29(11):1130-4. PubMed ID: 14641340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication.
    Takeuchi I; Hida Y; Makino K
    Biomed Mater Eng; 2018; 29(2):217-228. PubMed ID: 29457595
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Androgenetic Alopecia in Gender Minority Patients.
    Marks DH; Senna MM
    Dermatol Clin; 2020 Apr; 38(2):239-247. PubMed ID: 32115134
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safflower oil body nanoparticles deliver hFGF10 to hair follicles and reduce microinflammation to accelerate hair regeneration in androgenetic alopecia.
    Kong J; Qiang W; Jiang J; Hu X; Chen Y; Guo Y; Liu H; Sun S; Gao H; Zhang Y; Gao Y; Liu X; Liu X; Li H
    Int J Pharm; 2022 Mar; 616():121537. PubMed ID: 35150848
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study.
    Hossein Mostafa D; Samadi A; Niknam S; Nasrollahi SA; Guishard A; Firooz A
    J Pharm Pharm Sci; 2021; 24():191-199. PubMed ID: 33909554
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pediatric androgenetic alopecia: A review.
    Griggs J; Burroway B; Tosti A
    J Am Acad Dermatol; 2021 Nov; 85(5):1267-1273. PubMed ID: 31415838
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Male pattern baldness.
    Hogan DJ; Chamberlain M
    South Med J; 2000 Jul; 93(7):657-62. PubMed ID: 10923949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hair restoration approaches for early onset male androgenetic alopecia.
    Bhatti HA; Basra MK; Patel GK
    J Cosmet Dermatol; 2013 Sep; 12(3):223-31. PubMed ID: 23992164
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Topical minoxidil counteracts stress-induced hair growth inhibition in mice.
    Arck PC; Handjiski B; Peters EM; Hagen E; Klapp BF; Paus R
    Exp Dermatol; 2003 Oct; 12(5):580-90. PubMed ID: 14705798
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia.
    Gupta AK; Charrette A
    Skinmed; 2015; 13(3):185-9. PubMed ID: 26380504
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment.
    Fang JH; Liu CH; Hsu RS; Chen YY; Chiang WH; Wang HD; Hu SH
    Polymers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.